| Disrupted brain network functional dynamics and hyper‐correlation of structural and functional connectome topology in patients with breast cancer prior to treatment SR Kesler, M Adams, M Packer, V Rao, AM Henneghan, DW Blayney, ... Brain and behavior 7 (3), e00643, 2017 | 82 | 2017 |
| Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review A Henneghan Supportive Care in Cancer 24, 481-497, 2016 | 61 | 2016 |
| Measuring self-reported cancer-related cognitive impairment: recommendations from the cancer neuroscience initiative working group AM Henneghan, K Van Dyk, T Kaufmann, R Harrison, C Gibbons, ... JNCI: Journal of the National Cancer Institute 113 (12), 1625-1633, 2021 | 53 | 2021 |
| Cognitive impairment in non-critical, mild-to-moderate COVID-19 survivors AM Henneghan, KA Lewis, E Gill, SR Kesler Frontiers in Psychology 13, 770459, 2022 | 52 | 2022 |
| Modifiable correlates of perceived cognitive function in breast cancer survivors up to 10 years after chemotherapy completion A Henneghan, A Stuifbergen, H Becker, S Kesler, E King Journal of Cancer Survivorship 12, 224-233, 2018 | 46 | 2018 |
| Biofield therapies for symptom management in palliative and end-of-life care AM Henneghan, RN Schnyer American Journal of Hospice and Palliative Medicine® 32 (1), 90-100, 2015 | 38 | 2015 |
| A pilot study of a cognitive-behavioral intervention for breast cancer survivors H Becker Number 2/March 2017 44 (2), 255-264, 2017 | 36 | 2017 |
| Relationships between self‐reported sleep quality components and cognitive functioning in breast cancer survivors up to 10 years following chemotherapy AM Henneghan, P Carter, A Stuifbergan, B Parmelee, S Kesler Psycho‐oncology 27 (8), 1937-1943, 2018 | 35 | 2018 |
| Exploring relationships among peripheral amyloid beta, tau, cytokines, cognitive function, and psychosomatic symptoms in breast cancer survivors A Henneghan, AP Haley, S Kesler Biological Research for Nursing 22 (1), 126-138, 2020 | 31 | 2020 |
| Complementary and alternative medicine therapies as symptom management strategies for the late effects of breast cancer treatment AM Henneghan, T Harrison Journal of Holistic Nursing 33 (1), 84-97, 2015 | 30 | 2015 |
| Identifying cytokine predictors of cognitive functioning in breast cancer survivors up to 10 years post chemotherapy using machine learning AM Henneghan, O Palesh, M Harrison, SR Kesler Journal of neuroimmunology 320, 38-47, 2018 | 28 | 2018 |
| When do I get my brain back? Breast cancer survivors’ experiences of cognitive problems H Becker Number 2/April 2015 19 (2), 180-184, 2015 | 28 | 2015 |
| A cross-sectional exploration of cytokine–symptom networks in breast cancer survivors using network analysis A Henneghan, ML Wright, G Bourne, AC Sales Canadian Journal of Nursing Research 53 (3), 303-315, 2021 | 27 | 2021 |
| Cortical brain age from pre-treatment to post-chemotherapy in patients with breast cancer A Henneghan, V Rao, RA Harrison, M Karuturi, DW Blayney, O Palesh, ... Neurotoxicity research 37, 788-799, 2020 | 27 | 2020 |
| A randomized control trial of meditation compared to music listening to improve cognitive function for breast cancer survivors: Feasibility and acceptability AM Henneghan, H Becker, ML Harrison, K Inselmann, B Fico, H Schafer, ... Complementary therapies in clinical practice 41, 101228, 2020 | 23 | 2020 |
| Biomarkers panels can predict fatigue, depression and pain in persons living with HIV: A pilot study JA Zuñiga, ML Harrison, A Henneghan, AA García, S Kesler Applied Nursing Research 52, 151224, 2020 | 21 | 2020 |
| Perceived cognitive deficits in a sample of persons living with multiple sclerosis A Henneghan, A Stuifbergen, H Becker, V Kullberg, N Gloris Journal of Neuroscience Nursing 49 (5), 274-279, 2017 | 17 | 2017 |
| Neurocognitive impairment after hematopoietic stem cell transplant for hematologic malignancies: phenotype and mechanisms RA Harrison, N Sharafeldin, JL Rexer, B Streck, M Petersen, ... The oncologist 26 (11), e2021-e2033, 2021 | 13 | 2021 |
| Predicting patient reported outcomes of cognitive function using connectome-based predictive modeling in breast cancer AM Henneghan, C Gibbons, RA Harrison, ML Edwards, V Rao, ... Brain topography 33, 135-142, 2020 | 13 | 2020 |
| Describing cognitive function and psychosocial outcomes of COVID-19 survivors: a cross-sectional analysis AM Henneghan, KA Lewis, E Gill, OY Franco-Rocha, RD Vela, S Medick, ... Journal of the American Association of Nurse Practitioners 34 (3), 499-508, 2022 | 12 | 2022 |
